InsidersTradesSigma
Follow the PHARMANUTRA PR stock price and the full directors' dealings record of the company, a publicly traded company based in Italy. Shares are quoted on the IT market, under the authority of Consob. Operating in the Health Care sector, PHARMANUTRA PR has published 1 reports. Market capitalisation: €804.3m. The latest transaction was reported on 24 July 2024 (Other). Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,424 of 29,062 companies
61.9
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2024
Acerca de PHARMANUTRA PR
PHARMANUTRA PR es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XMIL. Se centra en el desarrollo y la comercialización de productos nutracéuticos y farmacéuticos.